Reduced-time-window sestamibi scanning for nonlocalized primary hyperparathyroidism. Academic Article uri icon

Overview

abstract

  • BACKGROUND: Technetium Tc 99m sestamibi scan is the standard of care for localizing parathyroid adenomas. METHODS AND MATERIAL: We performed a retrospective, single-institution study of 111 consecutive patients with primary hyperparathyroidism who underwent standard sestamibi scan for localization of a parathyroid lesion. A revised protocol of reduced-time-window sestamibi scan was used in nonlocalized patients. The protocol was composed of single-view scans at 15, 30, 45, and 120 minutes and tomograms at 60 minutes. RESULTS: Thirty-five patients underwent surgery at our institution. Thirty-one had adenomas, and 4 had hyperplasia. Three of 31 patients did not show localization on the standard scan and underwent reduced-time-window scans, which localized 2 more adenomas. These were confirmed at the time of surgery. CONCLUSION: We suggest that all patients with a high degree of suspicion for a parathyroid adenoma, which is not visualized by a standard scan, undergo a reduced-time-window scan.

publication date

  • October 1, 2000

Research

keywords

  • Adenoma
  • Hyperparathyroidism
  • Parathyroid Neoplasms
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi
  • Tomography, Emission-Computed

Identity

Scopus Document Identifier

  • 0033776006

Digital Object Identifier (DOI)

  • 10.1067/mhn.2000.109017

PubMed ID

  • 11020185

Additional Document Info

volume

  • 123

issue

  • 4